As copay accumulator programs have gained increasing traction, pharma companies have been working to find ways around them. PM360 asked six experts for their insights, including Sejal Jonas, Senior Director, Access Experience Team, Precision for Value. She predicts a 25-50% adoption by employers over the next two years.
